Humana (HUM) Stock Price, News & Analysis

+2.54 (+0.78%)
(As of 04/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.61 million shs
Average Volume
1.98 million shs
Market Capitalization
$39.55 billion
P/E Ratio
Dividend Yield
Price Target

Humana MarketRank™ Stock Analysis

Analyst Rating
2.47 Rating Score
38.6% Upside
$454.63 Price Target
Short Interest
2.04% of Float Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.41mentions of Humana in the last 14 days
Based on 34 Articles This Week
Insider Trading
Acquiring Shares
$200,064 Bought Last Quarter
Proj. Earnings Growth
From $16.06 to $22.86 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

5.00 out of 5 stars

Medical Sector

2nd out of 910 stocks

Hospital & Medical Service Plans Industry

1st out of 9 stocks

HUM stock logo

About Humana Stock (NYSE:HUM)

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Stock Price History

HUM Stock News Headlines

Humana earnings preview: what Wall Street is expecting
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Humana (NYSE:HUM) PT Lowered to $381.00
Humana (NYSE:HUM) Is Due To Pay A Dividend Of $0.885
The political life and lessons of George Atkins
Did You Get Your Free Bitcoin Yet?
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Humana (NYSE:HUM) Shares Gap Up to $314.64
Smart Money Is Betting Big In HUM Options
Humana (HUM) Set to Announce Quarterly Earnings on Wednesday
Wells Fargo Keeps Their Buy Rating on Humana (HUM)
Humana (NYSE:HUM) Shares Down 0.6%
The Analyst Landscape: 21 Takes On Humana
Humana AB: Humana acquires Team Olivia Norge AS
See More Headlines
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/26 Dividend
Last Earnings
Dividend Payable
Ex-Dividend for 4/26 Dividend
Next Earnings (Confirmed)
Dividend Payable
Fiscal Year End

Industry, Sector and Symbol

Hospital & medical service plans
Managed Health Care
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
19 Analysts


Net Income
$2.49 billion
Pretax Margin


Sales & Book Value

Annual Sales
$106.37 billion
Cash Flow
$34.22 per share
Book Value
$132.55 per share


Free Float
Market Cap
$39.55 billion

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Should I Buy Humana Stock? HUM Pros and Cons Explained


Here are some ways that investors could benefit from investing in Humana Inc.:

  • Humana's strong quarterly revenue growth of 17.9% year-over-year indicates a positive trend in the company's financial performance.
  • Humana's return on equity of 19.44% showcases the company's ability to generate profits from shareholders' investments.
  • Humana's consistent dividend payments, with a current annualized dividend of $3.54 and a yield of 1.01%, provide investors with a steady income stream.
  • Insider buying activity, such as Director Jorge S. Mesquita purchasing shares at an average price of $367.09, can signal confidence in the company's future prospects.
  • Positive analyst ratings and target prices suggest a favorable outlook for Humana's stock performance in the market.


Investors should be bearish about investing in Humana Inc. for these reasons:

  • Humana's payout ratio of 17.86% indicates a significant portion of earnings being distributed as dividends, potentially limiting reinvestment for growth.
  • Analyst downgrades, such as Argus lowering Humana from a "buy" to a "hold" rating, may reflect concerns about the company's future performance.
  • Market volatility and regulatory changes in the healthcare industry could impact Humana's operations and financial results unpredictably.
  • Competitive pressures from other healthcare providers and insurers may challenge Humana's market position and profitability in the long term.
  • Uncertainties surrounding healthcare policies and government regulations could introduce risks to Humana's business model and profitability.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Humana pros and cons to

HUM Stock Analysis - Frequently Asked Questions

Should I buy or sell Humana stock right now?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 10 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HUM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HUM, but not buy additional shares or sell existing shares.
View HUM analyst ratings
or view top-rated stocks.

What is Humana's stock price target for 2024?

19 analysts have issued 12-month price objectives for Humana's shares. Their HUM share price targets range from $310.00 to $630.00. On average, they predict the company's share price to reach $454.63 in the next twelve months. This suggests a possible upside of 38.6% from the stock's current price.
View analysts price targets for HUM
or view top-rated stocks among Wall Street analysts.

How have HUM shares performed in 2024?

Humana's stock was trading at $457.81 at the beginning of 2024. Since then, HUM stock has decreased by 28.4% and is now trading at $327.98.
View the best growth stocks for 2024 here

Are investors shorting Humana?

Humana saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,570,000 shares, an increase of 14.7% from the February 29th total of 2,240,000 shares. Based on an average trading volume of 1,940,000 shares, the days-to-cover ratio is currently 1.3 days. Currently, 2.1% of the shares of the company are short sold.
View Humana's Short Interest

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our HUM earnings forecast

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, April 24th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) issued its earnings results on Thursday, January, 25th. The insurance provider reported ($0.11) EPS for the quarter, missing the consensus estimate of $0.76 by $0.87. The insurance provider earned $26.46 billion during the quarter, compared to analysts' expectations of $25.47 billion. Humana had a net margin of 2.34% and a trailing twelve-month return on equity of 19.44%. Humana's revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.62 earnings per share.
Read the conference call transcript

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 18th. Stockholders of record on Friday, June 28th will be given a dividend of $0.885 per share on Friday, July 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date is Friday, June 28th.
Read our dividend analysis for HUM

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 1.08%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 17.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 15.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY 2024 earnings guidance on Saturday, March, 16th. The company provided earnings per share guidance of 16.000-16.000 for the period, compared to the consensus earnings per share estimate of 16.380. The company issued revenue guidance of -.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Who are Humana's major shareholders?

Humana's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (0.51%), Sumitomo Mitsui Trust Holdings Inc. (0.28%), Perpetual Ltd (0.09%), Raymond James & Associates (0.08%), State of Michigan Retirement System (0.03%) and Leeward Investments LLC MA (0.02%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Humana have any subsidiaries?
The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More
This page (NYSE:HUM) was last updated on 4/23/2024 by Staff

From Our Partners